Global Guillain-Barre Syndrome Market Share

Market Share of Global Guillain-Barre Syndrome Industry

The Guillain-Barre Syndrome market is moderately competitive and consists of several major players. Various strategies, such as the acquisition of the products by other companies, consolidate the market positions across the globe. Some of the companies currently dominating the market are Grifols S.A., CSL Limited, Octapharma AG, Kedrion Biopharma Inc., and Takeda Pharmaceutical Company Limited, among others.

Guillain-Barre Syndrome Market Leaders

1. CSL Behring LLC

2. Takeda Pharmaceutical Company Limited

3. Grifols SA

4. Kedrion Biopharma Inc.

5. Octapharma AG

*Disclaimer: Major Players sorted in no particular order